Skip to main navigation Skip to search Skip to main content

A cause and protective treatment for acute and progressive disability and grey matter atrophy

  • Erika A. Aguzzi (Lead / Corresponding author)
  • , Roshni A. Desai
  • , Zhiyuan Yang
  • , Andrew L. Davies
  • , Don Mahad
  • , Bernard Siow
  • , Ayse G. Yenicelik
  • , Radha Desai
  • , Eleni Giama
  • , Al Beshr Almasri
  • , Miranda Colman
  • , Celine Geywitz
  • , Lucas Schirmer
  • , Paul A. Felts
  • , Kenneth J. Smith

Research output: Contribution to journalArticlepeer-review

6 Downloads (Pure)

Abstract

Acutely inflamed CNS lesions can be sufficiently hypoxic to cause temporary neurological disability. A new experimental lesion reveals that brief hypoxia can also ignite a slow-burning atrophy of the grey matter, resulting in a lifetime of slowly progressive disability. The progressive disability eventually exceeds that observed acutely, indicating that acutely functioning tissue can nevertheless be destined to atrophy. Remarkably, both the temporary initial disability and the ensuing progressive disability and atrophy are significantly reduced if the acute hypoxia is avoided by four days of treatment with vasodilating nimodipine, or by simply breathing raised oxygen concentration. Thus, a lifetime of progressive disability and neurodegeneration can be the legacy of a few days of inflammatory hypoxia experienced in young adulthood, and avoided by maintaining lesion oxygenation. The findings may help to understand and treat some progressive neurological disorders, including multiple sclerosis.

Original languageEnglish
Pages (from-to)1144-1152
Number of pages9
JournalBrain
Volume149
Issue number4
Early online date15 Dec 2025
DOIs
Publication statusPublished - Apr 2026

Keywords

  • disease progression
  • grey matter atrophy
  • neurodegeneration
  • neuroinflammation
  • neuroprotection
  • relapse

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'A cause and protective treatment for acute and progressive disability and grey matter atrophy'. Together they form a unique fingerprint.

Cite this